Ketofol as induction agent in diabetic patients.

Objective: To evaluate the role of ketofol as induction agent in diabetic patients. Study Design: Randomized Control Trial. Setting: Department Anesthesia, Abwa Medical College, Faisalabad. Period: 01-12-21 to 01-05-22. Material & Methods: Patients after informed consent divided randomly into two groups 25 each. Group A receiving propofol 1.5 mg/kg and B 1:2 agent. The dose given was 1ml for every 5Kg. Standard 5 parameter monitoring with pulse oximetry, ECG, non invasive BP done starting from preoperative 2 minutes, minutes 10 given. MAP HR were monitored. Hemodynamic instability defined I) Heart rate >160/min or <50/min. II) MAP>120mmHg <60 mm Hg. Results: Total 50 patients included this study. each group. results show significant stability hemodynamics group B. Conclusion: Ketofol has better hemodynamic when used a 2:1 ratio. This makes it good choice specific patient population.